Literature DB >> 14723874

Fibronectin fragments cause release and degradation of collagen-binding molecules from equine explant cultures.

Anna Johnson1, Roger Smith, Tore Saxne, Mark Hickery, Dick Heinegård.   

Abstract

OBJECTIVE: Previous experiments have shown that addition of fragmented fibronectin can induce cartilage chondrolysis. In this study we investigated the fate of the collagen- and cell-binding molecules Cartilage oligomeric matrix protein (COMP) and chondroadherin.
DESIGN: Equine articular cartilage explants were stimulated with the C-terminal and the N-terminal heparin-binding fragments of fibronectin respectively, and the conditioned media were analysed by both quantitative (ELISA) and qualitative (mass spectrometry, Western blots) methods.
RESULTS: Both COMP and chondroadherin were released in a dose-dependent manner upon stimulation with the Hep II (C-terminal heparin-binding) fragment of fibronectin. The kinetics of release for the two components differed. Moreover, COMP was degraded while no fragments of chondroadherin could be detected. Stimulation with Hep II also induced production of nitric oxide in a dose-dependent manner. We compared effects of the Hep II fragment with that of Hep I (the N-terminal heparin-binding fragment of fibronectin) and found that while Hep I did indeed elicit release of COMP and chondroadherin, the response was less potent, and production of nitric oxide was negligible. The responses to both fragments were elicited within 24h.
CONCLUSIONS: We suggest that the events described here may be early, critical stages in cartilage destruction preceding collagen destruction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14723874     DOI: 10.1016/j.joca.2003.10.008

Source DB:  PubMed          Journal:  Osteoarthritis Cartilage        ISSN: 1063-4584            Impact factor:   6.576


  7 in total

1.  Degradation of extracellular matrix molecules in interleukin-1α treated bovine nasal cartilage.

Authors:  Behnaz Shohani; Mahmoud Orazizadeh; Mahmoud Hashemitabar; Dick Heinegard
Journal:  Iran Biomed J       Date:  2010-10

Review 2.  Anti-ADAMTS5 monoclonal antibodies: implications for aggrecanase inhibition in osteoarthritis.

Authors:  Suneel S Apte
Journal:  Biochem J       Date:  2016-01-01       Impact factor: 3.857

Review 3.  Analysing the role of endogenous matrix molecules in the development of osteoarthritis.

Authors:  Nidhi Sofat
Journal:  Int J Exp Pathol       Date:  2009-10       Impact factor: 1.925

4.  Fibronectin molecular status determination useful to differentiate between rheumatoid arthritis and systemic lupus erythematosus patients.

Authors:  Magdalena Przybysz; Krzysztof Borysewicz; Iwona Kątnik-Prastowska
Journal:  Rheumatol Int       Date:  2012-01-04       Impact factor: 2.631

5.  Fibronectin III 13-14 domains induce joint damage via Toll-like receptor 4 activation and synergize with interleukin-1 and tumour necrosis factor.

Authors:  Nidhi Sofat; Saralili Dipa Robertson; Robin Wait
Journal:  J Innate Immun       Date:  2011-10-12       Impact factor: 7.349

6.  Cartilage Oligomeric Matrix Protein (COMP): A Biomarker of Arthritis.

Authors:  Susan Tseng; A Hari Reddi; Paul E Di Cesare
Journal:  Biomark Insights       Date:  2009-02-17

7.  Development of a Cartilage Oligomeric Matrix Protein Neo-Epitope Assay for the Detection of Intra-Thecal Tendon Disease.

Authors:  Roger Smith; Patrik Önnerfjord; Kristin Holmgren; Shacko di Grado; Jayesh Dudhia
Journal:  Int J Mol Sci       Date:  2020-03-20       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.